MeSH tree: C14.280.238.625
Researchers at Michigan Medicine have devised a new biomarker-based strategy to screen for a rare and deadly complication caused by monoclonal antibodies used to treat several cancers.
Dec 20, 2022
0
47
A case of a 14-year-old girl who had a cardiac arrest at an overnight camp provides a roadmap of how to plan for a rare but often fatal event. The practice article is published in CMAJ (Canadian Medical Association Journal).
Dec 5, 2022
0
32
Almost three years into the pandemic, myths and misinformation remain widespread. Here we, a virologist and a public health researcher, debunk some common misconceptions about COVID.
Nov 29, 2022
2
86
The first blood test to diagnose inflammation of the heart muscle (myocarditis) could be in use in as little as a year, following the discovery of a molecular signal in the blood by Queen Mary University of London researchers. ...
Nov 24, 2022
0
114
A large study found that myocarditis after SARS-CoV-2 vaccination was rare but higher in younger males, especially after the second mRNA-1273 (Moderna) vaccine, suggesting that vaccine type, age and sex should be considered ...
Nov 21, 2022
0
254
Myocarditis is a complication that can occur in cancer patients treated with immune checkpoint inhibitors. Although the adverse event is rare—affecting less than 1% of patients given the immunotherapy—the mortality rate is ...
Nov 16, 2022
0
76
COVID cases in Australia appear to be on the increase, most likely due to community transmission of the omicron variant XBB. Meanwhile, a second omicron variant—BQ.1—is now being recorded in Australia.
Nov 11, 2022
0
70
Incidence of myocarditis, pericarditis or myopericarditis is two- to threefold higher after a second dose of the Moderna Spikevax COVID-19 vaccine when compared to the Pfizer BioNTech COVID-19 vaccine; however, overall cases ...
Nov 7, 2022
0
95
A comprehensive review and meta-analysis of published research confirm that young adults (40 years old and younger) have a slightly elevated risk for myocarditis or pericarditis after mRNA COVID-19 vaccination. The analysis ...
Nov 1, 2022
0
88
A third dose of the Moderna or Pfizer COVID-19 vaccine poses no more risk of heart inflammation than a second dose, a large study suggests. The findings could help allay concerns about risk going up with each additional dose.
Nov 1, 2022
0
41
